+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rapid Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Test Kits), Technology (Immunoassay, Lateral Flow Assay, Molecular Diagnostics), End User, Application - Global Forecast 2025-2030- Product Image
Rapid Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Test Kits), Technology (Immunoassay, Lateral Flow Assay, Molecular Diagnostics), End User, Application - Global Forecast 2025-2030- Product Image
Sale

Rapid Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Test Kits), Technology (Immunoassay, Lateral Flow Assay, Molecular Diagnostics), End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012257
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The rapid diagnostics market is evolving swiftly, driven by innovations transforming point-of-care testing and boosting the decentralized delivery of healthcare. Senior decision-makers seeking actionable insights and proven market strategies will find this report essential for navigating today’s complex diagnostic landscape.

Market Snapshot: Rapid Diagnostics Market Size & Growth

The Rapid Diagnostics Market grew from USD 34.03 billion in 2024 to USD 38.26 billion in 2025. It is expected to continue growing at a CAGR of 11.98%, reaching USD 67.14 billion by 2030. This substantial momentum is fueled by technology-driven improvements, accelerated adoption across diverse care settings, and growing demand for decentralized clinical solutions.

Scope & Segmentation: Rapid Diagnostics Industry Overview

  • Product Types: Instruments (benchtop, portable), reagents and consumables, and test kits. Each product group addresses unique clinical requirements and user preferences, supporting both high-throughput and mobile testing environments.
  • Technologies: Immunoassays, lateral flow assays (competitive, sandwich), and molecular diagnostics (including isothermal amplification, PCR). These platforms underpin a range of applications from quick infectious disease screening to advanced oncology diagnostics.
  • End Users: Clinics, home care, hospitals, and laboratories, each leveraging rapid diagnostics to streamline workflows or expand testing access.
  • Applications: Cardiac markers (creatine kinase MB, myoglobin, troponin), diabetes (type 1, type 2), infectious diseases (bacterial, parasitic, viral), and oncology. Expanding application breadth is unlocking new growth opportunities in acute and chronic care.
  • Regional Coverage: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning key Western European and emerging markets), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and more).
  • Competitive Landscape: Profiles of leading companies such as F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., bioMérieux SA, Hologic, Inc., DiaSorin S.p.A., and Quidel Corporation.

Key Takeaways for Decision-Makers

  • Advanced diagnostics are enabling rapid, reliable results closer to the patient, minimizing delays and reducing strain on centralized laboratories.
  • Integration of digital health, AI algorithms, and connectivity is enhancing the accuracy, predictive power, and quality assurance of rapid test platforms.
  • Cross-market regulatory harmonization is simplifying approval processes, speeding up product launches and enabling flexible adoption across jurisdictions.
  • User-centric designs lower training barriers, allowing broader adoption in both resource-rich and resource-limited environments including home care and remote clinics.
  • Strategic collaborations, combined with robust supply chain management, are shaping resilient market leaders capable of adapting to changing demand or regulatory shifts.
  • Regional variances, especially in emerging markets, highlight the importance of nuanced strategies tailored to infrastructure maturity, reimbursement ecosystems, and local partnerships.

Tariff Impact: Navigating 2025 Supply Chain and Manufacturing Challenges

Proposed United States tariffs in 2025 introduce new pressures on the rapid diagnostics landscape. Increased duties on key imported components may impact profit margins and require cost restructuring. Businesses are actively considering regional manufacturing hubs, restructuring supply chains, and volume-based contracting to protect market accessibility—especially in cost-sensitive settings such as community clinics. Scenario planning and agile manufacturing are central to mitigating disruption and safeguarding product availability for end users.

Methodology & Data Sources

This report synthesizes primary interviews with industry stakeholders—including clinical laboratorians and regulatory experts—with robust secondary research from leading journals, patent data, white papers, and industry conference findings. Analytical frameworks such as SWOT and Porter’s Five Forces support strategic analysis and data triangulation ensures consistency and reliability.

Why This Report Matters for Senior Leaders

  • Enables informed investment decisions through detailed segmentation, regional insights, and technology evaluations relevant for portfolio and partnership strategy.
  • Supports supply chain, regulatory, and go-to-market planning with practical actions for navigating tariffs, shifts in demand, and local compliance requirements.
  • Offers clear, actionable recommendations to enhance operational agility, productivity, and collaboration across diverse healthcare delivery models.

Conclusion: Strategic Guidance for the Next Phase

This report equips industry leaders to capitalize on growth opportunities, fine-tune strategies in a rapidly evolving market, and drive data-driven innovation. Position your organization to meet emerging challenges and secure a sustainable competitive edge in rapid diagnostics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of smartphone-based lateral flow assays for at-home COVID-19 and influenza screening enabling remote patient monitoring
5.2. Adoption of CRISPR-based point-of-care diagnostic kits for rapid on-site detection of emerging viral pathogens in low-resource settings
5.3. Expansion of multiplex nucleic acid amplification platforms for simultaneous identification of multiple antimicrobial resistance genes in clinical samples
5.4. Deployment of AI-enhanced biosensors for continuous real-time monitoring of critical biomarkers in intensive care units to reduce diagnostic delays
5.5. Collaboration between diagnostic manufacturers and telehealth providers to deliver decentralized testing services to underserved rural populations
5.6. Development of portable microfluidic lab-on-a-chip devices integrating sample preparation and analysis for rapid infectious disease detection
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rapid Diagnostics Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Benchtop
8.2.2. Portable
8.3. Reagents & Consumables
8.4. Test Kits
9. Rapid Diagnostics Market, by Technology
9.1. Introduction
9.2. Immunoassay
9.3. Lateral Flow Assay
9.3.1. Competitive
9.3.2. Sandwich
9.4. Molecular Diagnostics
9.4.1. Isothermal Amplification
9.4.2. Pcr
10. Rapid Diagnostics Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospitals
10.5. Laboratories
11. Rapid Diagnostics Market, by Application
11.1. Introduction
11.2. Cardiac Markers
11.2.1. Creatine Kinase Mb
11.2.2. Myoglobin
11.2.3. Troponin
11.3. Diabetes
11.3.1. Type 1 Diabetes
11.3.2. Type 2 Diabetes
11.4. Infectious Diseases
11.4.1. Bacterial Infections
11.4.2. Parasitic Infections
11.4.3. Viral Infections
11.5. Oncology
12. Americas Rapid Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Rapid Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Rapid Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.2. Abbott Laboratories
15.3.3. Danaher Corporation
15.3.4. Siemens Healthineers AG
15.3.5. Becton, Dickinson and Company
15.3.6. Thermo Fisher Scientific Inc.
15.3.7. bioMérieux SA
15.3.8. Hologic, Inc.
15.3.9. DiaSorin S.p.A.
15.3.10. Quidel Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. RAPID DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. RAPID DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 24. RAPID DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. RAPID DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. RAPID DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BENCHTOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PORTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COMPETITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY SANDWICH, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY SANDWICH, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CREATINE KINASE MB, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CREATINE KINASE MB, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MYOGLOBIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TROPONIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TROPONIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 132. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 133. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 136. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 137. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 138. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 139. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 144. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 145. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 146. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 147. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 148. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 149. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 166. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 167. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 168. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 251. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 258. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 259. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 268. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 269. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 270. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 271. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 278. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 279. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 288. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 289. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 290. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 311. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 314. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 315. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 318. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 319. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 320. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 321. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 326. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 327. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 328. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 329. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 330. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 331. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 334. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 335. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 336. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 337. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 338. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 339. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 340. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 341. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 344. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 345. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 346. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Hologic, Inc.
  • DiaSorin S.p.A.
  • Quidel Corporation

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 38.26 Billion
Forecasted Market Value ( USD ) by 2030 $ 67.14 Billion
Compound Annual Growth Rate11.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Paper Diagnostics Market by Application, Platform, End User, Distribution Channel, Product Type, Material - Global Forecast to 2030 - Product Image

Paper Diagnostics Market by Application, Platform, End User, Distribution Channel, Product Type, Material - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Diagnostic Substances Market by Product Type, End-User, Application - Global Forecast to 2030 - Product Image

Diagnostic Substances Market by Product Type, End-User, Application - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent), By Application (Infectious Disease, Oncology), By End Use (Hospitals & Clinics, Diagnostic Laboratory, Home Care Settings), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent), By Application (Infectious Disease, Oncology), By End Use (Hospitals & Clinics, Diagnostic Laboratory, Home Care Settings), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Human Metapneumovirus Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR Based Diagnostics, Microarray Technology), By End-use (Hospitals & Clinics, Diagnostic & Reference Laboratories), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Human Metapneumovirus Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR Based Diagnostics, Microarray Technology), By End-use (Hospitals & Clinics, Diagnostic & Reference Laboratories), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 160 Pages
  • Global
From
Rapid Medical Diagnostic Kits - Global Strategic Business Report - Product Image

Rapid Medical Diagnostic Kits - Global Strategic Business Report

  • Report
  • 166 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.